항 GD1a 항체와 연관된 급성 운동 전도차단 신경병증
Anti-GD1a Antibody-associated Acute Motor Conduction Block Neuropathy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The Guillain-Barre syndrome (GBS) is characterized by acute flaccid paralysis, areflexia, and albuminocytologic dissociation. GBS has several subtypes that are divided by clinical, electrophysiological, and pathological findings. Acute motor axonal neuropathy (AMAN) as a main form of Guillain-Barre syndrome was originally characterized by primary axonal degeneration. AMAN has been associated with extensive axonal loss and poor outcome. However, there are some cases of AMAN with rapid resolution of weakness and nerve conduction block. Rapid recovery from conduction block without temporal dispersion is called reversible conduction failure (RCF). Previous reports indicated anti-GM1 antibodies are related to AMAN with RCF. However, we experienced anti-GD1a and anti-GT1b antibodies positive and anti-GM1 antibody negative AMAN patient showing RCF. It suggests AMAN with RCF may be related to other anti ganglioside antibodies as well as anti-GM1 antibody. Moreover we would like to emphasize serial nerve conduction studies to confirm subtypes of GBS and also predict different outcomes.
Abstract
The Guillain-Barre syndrome (GBS) is characterized by acute flaccid paralysis, areflexia, and albuminocytologic dissociation. GBS has several subtypes that are divided by clinical, electrophysiological, and pathological findings. Acute motor axonal neuropathy (AMAN) as a main form of Guillain-Barre syndrome was originally characterized by primary axonal degeneration. AMAN has been associated with extensive axonal loss and poor outcome. However, there are some cases of AMAN with rapid resolution of weakness and nerve conduction block. Rapid recovery from conduction block without temporal dispersion is called reversible conduction failure (RCF). Previous reports indicated anti-GM1 antibodies are related to AMAN with RCF. However, we experienced anti-GD1a and anti-GT1b antibodies positive and anti-GM1 antibody negative AMAN patient showing RCF. It suggests AMAN with RCF may be related to other anti ganglioside antibodies as well as anti-GM1 antibody. Moreover we would like to emphasize serial nerve conduction studies to confirm subtypes of GBS and also predict different outcomes.
참고문헌 (10)
- Capasso M, "Acute motor conduction block neuropathy Another Guillain-Barre syndrome variant", Neurology, 61, pp.617~622 (2003)
- Kuwabara S, "IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome", Ann neurol, 44, pp.202~208 (1998)
- Duyff RF, "Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study", J Neurol Neurosurg Psychiatry, 68, pp.750~755 (2000)
- Keiichiro S, "Dysfunction of nodes of Ranvier: A mechanism for anti-ganglioside antibody-mediated neuropathies", Exp Neurol, 233, pp.534~542 (2012)
- Olney R, "Consensus criteria for the diagnosis of partial conduction block", Muscle Nerve, 22(suppl 8), pp.S225~S229 (1999)
- Norito K, "Conduction block in acute motor axonal neuropathy", Brain, 133, pp.2897~2908 (2010)
- Kim JK, "Anti-Ganglioside Antibodies and Guillain-Barre Syndrome", Korean Journal of Neuromuscular Disorders, 2, pp.14~20 (2010)
- Susuki K, "Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers", J Neurosci, 27, pp.3956~3967 (2007)
- Uncini A, "A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies", Exp neurol, 235, pp.513~516 (2012)
- Fiore M, "Case of acute motor conduction block neuropathy (AMCBN)", Muscle Nerve, 39, pp.224~226 (2009)